Time |
Session |
Room |
7:00 – 8:00 AM |
Continental Breakfast |
Peabody Grand Ballroom Foyer West |
7:30 – 8:00 AM |
General Assembly |
Peabody Grand Ballroom A, B & C |
8:00 – 9:30 PM |
The World Workshop on Oral Medicine |
Peabody Grand Ballroom A, B & C |
8:00 – 8:15 AM |
Infective Endocarditis Katherine France
|
8:15 – 8:30 AM |
The Future of Oral Medicine Dr. Suhail Al-Amad & Dr. Luiz Gueiros
|
8:30 – 8:45 AM |
Outcome Domains/Measure in OLP Rosa-Maria Lopez-Pintor & Jairo Robledo |
8:45 – 9:00 AM |
Outcome Domains/Measures in Dry Mouth Alan Roger Santos-Silva & Sven Nicklander
|
9:00 – 9:30 AM |
Outcome Domains Consensus Poll Rosa-Maria Lopez-Pintor, Jennifer Taylor, Alan Roger Santos-Silva & Sven Nicklander
|
9:30 – 10:00 AM |
Morning Break |
Peabody Grand Ballroom Foyer West |
10:00 – 11:00 AM |
Jonathan Ship Lecture: The Intersection of Decision-Making in our Lives as Humans and Healthcare Practitioners Craig Miller, DMD Moderator: Tom Sollecito, DMD, FDS, RCSEd
This talk reviews the core principles of ethical decision-making in healthcare and emphasizes how ethical decision-making can be used to approach ethical dilemmas in healthcare practice.
Learning Objectives:
- Understand the decision-making process.
- Recognize the individual and collective factors that influence decision-making.
- Appreciate how to utilize “decision-hygiene” to minimize biases and noise.
|
Peabody Grand Ballroom A, B & C |
11:00 – 12:00 PM |
OTOD Session: Resident Case Reports Oral Mucositis in aChild with Rare Medical Conditions, Eman Alamodi, Trismus in A Young Adult, Sara Aldosary, Paresthesia as a Presenting Sign/Symptom of MRONJ in Patients with Multiple Myeloma, Bella Ly, Good’s Syndrome with Lichen Planus, HSV- Related Oral Ulcer, and Refractory Oral Candidiasis, Abrar Khalid Bakhsh, Severe, Refractory, Oropharyngeal Vesiculobullous Lesions–The Frustration Of Linear IgA-Bullous Disease, Blake Bachner
|
Peabody Grand Ballroom A, B & C |
12:00 – 1:30 PM |
Lunch on your own |
|
12:00 – 1:30 PM |
Quad O Lunch |
Cockrell Room |
1:30 – 3:00 PM |
Plenary II: Combating Cancer Mortality: A sneak peek into the future of cancer detection Moderators: Dr. Arwa Farag |
Peabody Grand Ballroom A, B & C
|
1:30 – 1:55 PM |
Methylation-based Multi-Cancer Early Detection Eric A. Klein, MD
The multi-cancer early detection (MCED) is an innovative test used to complement existing screening modalities. This promising approach may increase the chance of detecting cancers at early stages, through population screening, and potentially improve disease-related outcomes.
Learning objectives:
- Demonstrate the scientific bases for multi-cancer early detection (MCED) test.
- Display the evidence-based multi-center investigations that explored and validated the prediction accuracy of MCED.
- Discuss the future utilization of MCED and how it may complement the existing single-cancer screening tests to reduced cancer-related mortality
|
1:55 – 2:20 PM |
Early Detection of OSCC and OPMD: What Lies in the Epithelium and Beyond? Sook-Bin Woo, DMD, Ms, DMD
This talk will highlight some of the new diagnostic criteria for oral dysplasia that does not rely predominantly on cytologic features. It also will briefly discuss current investigational techniques for the diagnosis of dysplasia including DNA-image cytometry, quantitative tissue phenotype and use of liquid biopsies in head and neck cancer detection.
Learning objectives:
-
Familiarize with the current investigational modalities that may assist in detection of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs).
-
Provide an update for the potential phenotypic and genotypic markers that may help detect malignancies or predict the risk for malignant transformation.
-
Identify the barriers and facilitators for utilizing these detection modalities in both research and clinical practice.
|
2:20 – 2:45 PM |
Oral Potentially Malignant Disorders: Evidence on malignant transformation Saman Warnakulasuriya, BDS, FDSRCS (Eng), FDSRCS (Edin), FDSRCPS. (Glasg), PhD(Glasg), DSc, FKC
Oral potentially malignant disorders (OPMDs) are associated with an increased risk of oral/lip cancers transformation. This talk highlights the risk factors tied to OPMDs malignant transformation based on data from longitudinal observational investigations. It also discusses the pivotal need to develop a risk assessment and stratification tool that may optimize oral cancer surveillance.
Learning objectives:
- Familiarize with the updated OPMDs nomenclature and classification based on the recent World Health Organization (WHO) Collaborating Centre for Oral Cancer workshop.
- Appreciate the risk factors tied to OPMDs malignant transformation based on data from longitudinal observational investigations.
- Appreciate the pivotal need to develop a risk assessment/stratification tool that may optimize oral cancer surveillance.
|
2:45 – 3:00 PM |
Plenary 2: Panel Discussion |
3:00 – 3:30 PM |
Afternoon Break |
Peabody Grand Ballroom Foyer West |
3:30 – 5:00 PM |
Oral Abstracts Stimulated Whole Saliva Flow Rates Decrease Over Time, Thomas Fry, New Investigator Global Assessment Scale in Lichen Planus: OLP IGA, Caroline Bissonnette, Prevalence Of Orofacial Immune-Related Adverse Events (irAEs): A Large Retrospective Study, Anette Paulina Vistoso Monreal, DDS, MS, DABOP
Medication-related osteonecrosis of the jaw: Prevalence of extra-oral signs as a presenting complaint, Sara Whitefield, The Epidemiology of Glossodynia in the United States: A Large Hospital-based Database Study, Zena Khorfan, Salivary Gland Dysfunction of Radioiodine and Human Thyroid Stimulating Hormone: A Meta-analysis, Gulshan Sunavala, Relationship Between Clinician-Measured Health Outcomes And Patient-Reported Outcomes Following Head Neck Radiation Therapy, Annu Singh, |
Peabody Grand Ballroom A, B & C |
6:00 – 7:00 PM |
Oral Medicine Residents and New Graduates Meeting: Facing the Future – Together
Residents/PDC Committee
|
Jackson Room |
7:00 – 10:00 PM |
Presidents Awards Banquet |
Peabody Rooftop & Skyway |